VERKAZIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Verkazia, and what generic alternatives are available?
Verkazia is a drug marketed by Harrow Eye and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and fifteen patent family members in twenty-three countries.
The generic ingredient in VERKAZIA is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Verkazia
A generic version of VERKAZIA was approved as cyclosporine by HIKMA on October 29th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERKAZIA?
- What are the global sales for VERKAZIA?
- What is Average Wholesale Price for VERKAZIA?
Summary for VERKAZIA
International Patents: | 115 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 4,376 |
Drug Prices: | Drug price information for VERKAZIA |
What excipients (inactive ingredients) are in VERKAZIA? | VERKAZIA excipients list |
DailyMed Link: | VERKAZIA at DailyMed |
Pharmacology for VERKAZIA
Drug Class | Calcineurin Inhibitor Immunosuppressant |
Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
US Patents and Regulatory Information for VERKAZIA
VERKAZIA is protected by seven US patents and two FDA Regulatory Exclusivities.
Patents protecting VERKAZIA
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions containing quaternary ammonium compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Emulsion compositions containing cetalkonium chloride
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
FDA Regulatory Exclusivity protecting VERKAZIA
FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS (VKC) IN CHILDREN AND ADULTS
Exclusivity Expiration: ⤷ Sign Up
NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VERKAZIA
See the table below for patents covering VERKAZIA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 101056615 | Ophthalmic oil-in-water type emulsion with stable positive zeta potential | ⤷ Sign Up |
European Patent Office | 1937212 | EMULSIONS OPHTALMIQUES CONTENANT DES PROSTAGLANDINES (OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS) | ⤷ Sign Up |
South Korea | 101333923 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VERKAZIA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1809237 | C01809237/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: CICLOSPORIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66093 08.09.2016 |
1809237 | 122015000043 | Germany | ⤷ Sign Up | PRODUCT NAME: OPHTHALMISCHE EMULSION ENTHALTEND CYCLOSPORIN; REGISTRATION NO/DATE: EU/1/15/990 20150319 |
1809237 | CR 2015 00030 | Denmark | ⤷ Sign Up | PRODUCT NAME: CYCLOSPORIN; REG. NO/DATE: EU/1/15/990/001-002 20150323 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |